findmyKOL
Clinical trialNCT06421376RecruitingPhase 2Interventional

Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer

SponsorCancer Institute and Hospital, Chinese Academy of Medical SciencesEnrollment60ChemoradiotherapyEsophageal CancerImmunotherapyInduction TherapySurgery
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Xin Wang

    Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC)

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Anyang Cancer Hospital

    Anyang, Henan, China

    Not, yet, recruiting
  • the First Affiliated Hospital of Xinxiang Medical University

    Xinxiang, Henan, China

    Not, yet, recruiting
  • Department of Radiation Oncology, National Cancer Center/national Clinical Research Center for Cancer/cancer Hospital, Chinese Academy of Medical Sciences (cams) and Peking Union Medical College (pumc)

    Beijing, China

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 May 2024
Primary completion
31 Dec 2026
Completion
31 Dec 2027
Last update posted
30 May 2025
Registered enrollment
60
Registry id
NCT06421376

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.